ArticleFrontiers in oncology2022

Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus Standard Chemoradiotherapy: 5-Year Follow-Up.

Mai Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.